Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 96

    1.

    Composite outcomes in cardiovascular research: a survey of randomized trials.

    Lim E, Brown A, Helmy A, Mussa S, Altman DG.

    Ann Intern Med. 2008 Nov 4;149(9):612-7.PMID: 18981486 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Composite outcomes in randomized trials: greater precision but with greater uncertainty?

    Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C.

    JAMA. 2003 May 21;289(19):2554-9.PMID: 12759327 [PubMed - indexed for MEDLINE]Related articles

    3.

    Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials.

    Ferreira-González I, Busse JW, Heels-Ansdell D, Montori VM, Akl EA, Bryant DM, Alonso-Coello P, Alonso J, Worster A, Upadhye S, Jaeschke R, Schünemann HJ, Permanyer-Miralda G, Pacheco-Huergo V, Domingo-Salvany A, Wu P, Mills EJ, Guyatt GH.

    BMJ. 2007 Apr 14;334(7597):786. Epub 2007 Apr 2. Review.PMID: 17403713 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

    Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

    Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774. PMID: 12869717 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention.

    Kip KE, Hollabaugh K, Marroquin OC, Williams DO.

    J Am Coll Cardiol. 2008 Feb 19;51(7):701-7. Review.PMID: 18279733 [PubMed - indexed for MEDLINE]Related articles

    6.

    The evaluation of the results of clinical trials: surrogate end points and composite end points.

    Gensini GF, Conti AA.

    Minerva Med. 2004 Feb;95(1):71-5.PMID: 15041928 [PubMed - indexed for MEDLINE]Related articles

    7.

    Randomized, controlled clinical trials in sepsis: has methodological quality improved over time?

    Graf J, Doig GS, Cook DJ, Vincent JL, Sibbald WJ.

    Crit Care Med. 2002 Feb;30(2):461-72. Review.PMID: 11889331 [PubMed - indexed for MEDLINE]Related articles

    8.

    Statin use after renal transplantation: a systematic quality review of trial-based evidence.

    Lentine KL, Brennan DC.

    Nephrol Dial Transplant. 2004 Sep;19(9):2378-86. Epub 2004 Jul 13. Review.PMID: 15252155 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Do we measure the right end points? A systematic review of primary outcomes in recent neonatal randomized clinical trials.

    Zhang B, Schmidt B.

    J Pediatr. 2001 Jan;138(1):76-80. Review.PMID: 11148516 [PubMed - indexed for MEDLINE]Related articles

    10.

    Key issues in end point selection for heart failure trials: composite end points.

    Neaton JD, Gray G, Zuckerman BD, Konstam MA.

    J Card Fail. 2005 Oct;11(8):567-75.PMID: 16230258 [PubMed - indexed for MEDLINE]Related articles

    11.

    Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.

    Marshall M, Crowther R, Almaraz-Serrano A, Creed F, Sledge W, Kluiter H, Roberts C, Hill E, Wiersma D, Bond GR, Huxley P, Tyrer P.

    Health Technol Assess. 2001;5(21):1-75. Review.PMID: 11532238 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

    Vrecer M, Turk S, Drinovec J, Mrhar A.

    Int J Clin Pharmacol Ther. 2003 Dec;41(12):567-77.PMID: 14692706 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Controlled randomized clinical trials]

    Jaillon P.

    Bull Acad Natl Med. 2007 Apr-May;191(4-5):739-56; discussion 756-8. French. PMID: 18225427 [PubMed - indexed for MEDLINE]Related articles

    14.

    Survival end point reporting in randomized cancer clinical trials: a review of major journals.

    Mathoulin-Pelissier S, Gourgou-Bourgade S, Bonnetain F, Kramar A.

    J Clin Oncol. 2008 Aug 1;26(22):3721-6. Review.PMID: 18669458 [PubMed - indexed for MEDLINE]Related articles

    15.

    Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.

    Lincoff AM, Wolski K, Nicholls SJ, Nissen SE.

    JAMA. 2007 Sep 12;298(10):1180-8.PMID: 17848652 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.

    Nissen SE, Wolski K, Topol EJ.

    JAMA. 2005 Nov 23;294(20):2581-6. Epub 2005 Oct 20.PMID: 16239637 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.

    MacLeod A, Daly C, Khan I, Vale L, Campbell M, Wallace S, Cody J, Donaldson C, Grant A.

    Cochrane Database Syst Rev. 2001;(3):CD003234. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003234. PMID: 11687058 [PubMed - indexed for MEDLINE]Related articles

    18.

    Composite outcomes in clinical trials: uses and problems.

    Carneiro AV.

    Rev Port Cardiol. 2003 Oct;22(10):1253-63. English, Portuguese. PMID: 14708338 [PubMed - indexed for MEDLINE]Related articles

    19.

    Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.

    O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Piña IL; HF-ACTION Investigators.

    JAMA. 2009 Apr 8;301(14):1439-50.PMID: 19351941 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005.

    Ridker PM, Torres J.

    JAMA. 2006 May 17;295(19):2270-4. Erratum in: JAMA. 2006 Jun 21;295(23):2726. PMID: 16705108 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data